Early Palmar Nodule Points to Dupuytren Disease
A 60-year-old man with a firm, painful nodule and pitting in the palm fits a classic presentation of Dupuytren disease. The lesion began a year earlier and is now interfering with tool use, which is often the first bedside clue that a benign-looking palm nodule has begun to affect function. In this setting, the diagnosis is clinical: a palpable pit, nodule, or cord on the volar hand surface is usually enough to establish the disease without imaging. Early nodules can hurt before they harden into cords, and the transition from nodule to contracture is the step that changes a nuisance into a functional problem.
The pathology is a fibroproliferative disorder of the palmar fascia. Excess fibrous tissue contracts over time, most often starting in the palm and then pulling the metacarpophalangeal joint into flexion before involving the proximal interphalangeal joint. A painless cord in the palm may look deceptively limited on exam, yet it can steadily tighten into a fixed deformity that affects grip, glove use, hygiene, and hand positioning. In this patient, the absence of trauma, infection, or foreign body makes a structural fibromatosis far more plausible than an inflammatory or traumatic hand lesion.
Genetic Risk, Repetitive Use, and the Pattern of Disease
Dupuytren disease is primarily genetic, but the clinical picture is shaped by several recognized risk factors. Male sex, northern European ancestry, smoking, alcohol use, diabetes, hand-transmitted mechanical exposure, and epilepsy all increase risk. Age also matters, with incidence rising after 50 years. In practical terms, the disease often appears in the very patients who rely on their hands for repetitive manual work, which is why a complaint about holding tools can be the first functional red flag rather than a late-stage symptom.
Similar fibromatoses can appear elsewhere. Ledderhose disease affects the plantar fascia, Garrod pads involve the dorsum of the proximal interphalangeal joint, and Peyronie disease affects the penis. When these conditions cluster, the broader biologic tendency is toward abnormal fibrotic proliferation rather than a single isolated hand problem. A history of early onset before age 50, family history, bilateral disease, associated fibromatoses, or rapid progression signals a Dupuytren diathesis, a high-risk phenotype that deserves closer surveillance and earlier specialist referral.
Bedside Diagnosis and the Tabletop Test
Physical examination remains the cornerstone of diagnosis. Palmar pits, nodules, and cords along the volar hand surface are the decisive findings, and imaging is not routinely needed when the exam is clear. The Hueston tabletop test adds functional meaning to the findings: if the patient cannot place the palm flat on a table, the disease has usually progressed to a level where procedural intervention becomes more likely. This test is simple, fast, and highly useful in primary care because it ties anatomy to real-world hand function.
A careful differential still matters. Hand tumors such as inclusion cysts, giant cell tumors of the tendon sheath, and retinacular cysts can present as nodules, but they do not produce the progressive palmar banding and cord formation typical of Dupuytren disease. Ultrasonography can help separate these diagnoses when uncertainty remains, though a straightforward presentation rarely needs it. The clinical distinction is especially important when pain is present, because pain can tempt clinicians to look for trauma or infection even when the pattern is fibromatous.
Painful nodules can be the earliest stage of the disease.
Observation First, Intervention When Function Starts to Slip
Initial management depends on how much the hand is being affected. Many patients progress slowly and never need intervention, so education and observation are reasonable in the early stage. A systematic review found inconclusive evidence for physiotherapy or splinting, which means these approaches cannot be relied on to change the disease course. They may still be used in selected patients, but the evidence does not support presenting them as disease-modifying therapy.
Intralesional corticosteroid injection may reduce pain, but it does not remove the disease process. Skin atrophy and depigmentation are important adverse effects and should be part of counseling before injection is offered. Early nodules have also been referred for radiotherapy, but the evidence base is limited and long-term outcomes remain uncertain. In Canada, radiotherapy is available only at select centers and is not routinely offered, so referral should be coordinated with a hand surgeon or a radiation oncologist experienced in benign hand fibromatoses.
Referral Thresholds and Procedural Options
Referral to a hand or plastic surgeon is indicated when function is impaired, progression is rapid, or diagnosis remains uncertain. A failed tabletop test is a common trigger for specialist evaluation because it captures contracture in a way patients and clinicians can both appreciate. Trigger finger may coexist with early Dupuytren disease and can further reduce hand use, adding another reason not to wait for severe deformity before seeking specialist input.
Several procedural options are available once contracture develops. Percutaneous needle aponeurotomy cuts the cord with the bevel of a needle. Fasciectomy removes the diseased fascia, and dermatofasciectomy removes both the diseased tissue and overlying skin, replacing it with a graft. In simpler cases, surgery may be performed under local anesthesia, and postoperative hand therapy is not always required. Each approach aims to restore extension, but none eliminates the tendency for recurrence, so procedure choice often reflects the balance between invasiveness, recovery time, and expected durability.
Direct injection of collagenase lyses diseased fascial cords and has indications and outcomes comparable to needle aponeurotomy in a meta-analysis of randomized trials, but this option is no longer available in Canada. For clinicians, the practical implication is straightforward: local availability and regional practice patterns now shape procedural counseling as much as disease severity does.
Chronic Course, Recurrence, and the Case Two Years Later
Dupuytren disease is chronic and often progresses gradually toward contracture, although rapid worsening occurs in a minority of patients. The patient in this case returned two years later with a firm, painless cord at the original nodule site and increasing difficulty straightening the fingers, gripping large objects, putting on gloves, and washing his face. Examination showed a 90° proximal interphalangeal contracture of the fifth finger and a positive tabletop test, findings that left little doubt about loss of hand function. He was referred to a plastic surgeon and chose surgery after further counseling.
Recurrence risk should be discussed before any intervention because the disease can return after needle, open, or more extensive surgical treatment. The recurrence profile varies by procedure, and no option guarantees permanent correction. For primary care, the main clinical task is not simply naming the diagnosis; it is identifying the stage at which the hand is beginning to lose extension, then moving the patient to specialist care before the deformity becomes harder to reverse.